Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (14)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (2)
Events (1)
- Past Events (1)
Guidance (151)
- Administering (11)
- Dosing (2)
- Medication Safety (1)
- Patient Group Directions (151)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (87)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Co-amoxiclav (1)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (4)
- Emtricitabine + Tenofovir alafenamide (1)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Hyoscine butylbromide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Malathion (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (2)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Permethrin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Publications (93)
- Explainer videos (3)
- Research and audits (3)
- Templates (87)
Specialty (79)
- Infection and infectious diseases (31)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (13)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (14)
- Skin disorders (14)
- Smoking cessation (2)
- Vaccinating (4)
Training and Development (5)

Tranexamic acid injection for treatment of severe haemorrhage

9 April 2026SPS PGD template for administering tranexamic acid injection for treatment of severe haemorrhage by registered Paramedics and Nurses.

Authorising Independent Healthcare Provider (IHP) PGDs

8 April 2026Considerations are needed when NHS or local authorities commission services using PGDs from independent healthcare providers.

Patient Group Direction use in services provided by multiple organisations

8 April 2026Principles to be considered are outlined for Patient Group Directions used in the provision of medicines/vaccines in services provided by multiple organisations

Off-label or unlicensed product use under HMR 2012 exemptions

8 April 2026A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012

Delegating PGD authorisation by a Local Authority

8 April 2026It is not permitted for a Local Authority to delegate the authorisation of Patient Group Directions using a Section 75 partnership agreement.

PGD use in Hospital at Home services, including Virtual Wards

8 April 2026Considerations required before implementing Patient Group Direction (PGDs) in Hospital at Home, including virtual ward, services

Repeat supply or administration of medicines under PGD

8 April 2026Patient Group Directions are not an appropriate mechanism for regular repeated supplies or administration of a medicine; repeat medicines should be prescribed.

Hydrogen peroxide 1% cream for impetigo

8 April 2026SPS protocol template (registered pharmacists and in a registered pharmacy) and PGD template for the supply of hydrogen peroxide 1% cream for localised impetigo

Managing Patient Group Directions following amendments or changes

8 April 2026There are requirements for all Patient Group Directions (PGDs) to be resigned or reauthorised after any amendment or change made during its valid to/from dates

Off label medicine use under a Patient Group Direction

8 April 2026This article explains the legislation and guidance on the use of PGDs when a licensed medicine is to be used outside its licence ('off-label').